LT - 5-metoksi-N,N-dimetiltriptaminas (5-MeO-DMT), skirtas didžiosios depresijos sutrikimo gydymui
EN - 5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR TREATING MAJOR DEPRESSION
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
A61K 31/4045 |
(2006.01) |
|
|
A61P 25/24 |
(2006.01) |
European patent
(11) |
Number of the document |
3927337 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
20710059.5 |
|
Date of filing the European patent application |
2020-02-24 |
(97) |
Date of publication of the European application |
2021-12-29 |
(45) |
Date of publication and mention of the grant of the patent |
2024-02-14
|
(46) |
Date of publication of the claims translation |
2024-07-10
|
PCT application
(86) |
Number |
PCT/EP2020/054803 |
|
Date |
2020-02-24 |
PCT application publication
(87) |
Number |
WO 2020/169850 |
|
Date |
2020-08-27 |
Priority applications
(30) |
Number |
Date |
Country code |
|
19158774 |
2019-02-22
|
EP |
Inventors
(72) |
TERWEY, Theis , DE
|
Grantee
(73) |
GH Research Ireland Limited ,
Joshua Dawson House Dawson Street, D02 RY95 Dublin 2,
IE
|
Attorney or representative
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
(54) |
5-metoksi-N,N-dimetiltriptaminas (5-MeO-DMT), skirtas didžiosios depresijos sutrikimo gydymui |
|
5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR TREATING MAJOR DEPRESSION |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-02-19 |
6 |
139.00
EUR
|
Next renewal fee
|
2026-02-24 |